Showing 4401-4410 of 8214 results for "".
- Third Harmonic Bio Appoints Thomas M. Soloway to its Board of Directorshttps://practicaldermatology.com/news/third-harmonic-bio-appoints-thomas-m-soloway-to-its-board-of-directors/2461292/Thomas M. Soloway is now a member of Third Harmonic Bio, Inc.’s Board of Directors. Mr. Soloway brings more than 25 years of experience in the life sciences industry, with senior roles in strategy, operations, corporate finance and venture capital to the company,
- Tarek El Hoss Named Sr. Vice President of Market Development and Sales at MedXhttps://practicaldermatology.com/news/tarek-el-hoss-named-sr-vice-president-of-market-development-and-sales-at-medx/2461287/Tarek El Hoss is MedX Health Corp.’s New Senior Vice President, Market Development and Sales. Mr. El Hoss will oversee strategic global growth initiatives and will be responsible for the deployment of market development strategies to impact immediate revenue generation and g
- FDA Approves JUVÉDERM VOLUX XC for Jawline Definitionhttps://practicaldermatology.com/news/fda-approved-juvederm-volux-xc-for-jawline-definition/2461286/The U.S. FDA has given its nod to JUVÉDERM VOLUX XC for the improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition. "The approval of JUVÉDERM VOLUX XC represents the largest leap in innovation for ou
- CeraVe, Top Derms, and Skincare Enthusiasts Partner to Teach Consumers to #CleanseLikeaDermhttps://practicaldermatology.com/news/cerave-top-derms-and-skincare-enthusiasts-partner-to-teach-consumers-to-cleanselikeaderm/2461283/CeraVe is teaming up with board-certified dermatologists and two of the biggest dermatologist influencers on social media today – Dr. Dustin Portela (@208skindoc) and Dr. Michelle Henry (@drmichellehenry) – to host a global livestreamed event with skincare enthusiast and content creat
- The Foundation for Research and Education in Dermatology Welcomes Matt L. Leavitt, DO to Boardhttps://practicaldermatology.com/news/the-foundation-for-research-and-education-in-dermatology-welcomes-matt-l-leavitt-do-to-board/2461281/The Foundation for Research and Education in Dermatology (FRED), has named Matt L. Leavitt, DO as new member of its board. The Foundation says this decision marks the latest step in expanding its leadership at the executive and advisory levels. Dr. Leavitt is a board-certified derm
- Almirall Launches New Call for Innovative Therapies for Skin Diseaseshttps://practicaldermatology.com/news/almirall-launches-new-call-for-innovative-therapies-for-skin-diseases/2461279/Almirall SA has launched its seventh call for proposals to establish collaborations in dermatological research through AlmirallShare, it
- Dermaliq Forms New Scientific and Medical Advisory Boardhttps://practicaldermatology.com/news/dermaliq-forms-new-scientific-and-medical-advisory-board/2461270/Dermaliq Therapeutics, Inc. has formed a Scientific and Medical Advisory Board. New members include Gordon Dow, Xavier Yon, Michael Kuligowski, MD, PhD, and R. Todd Plott, MD. The Advisory Board is composed of key clinical investigators and industry veterans in the field who suppor
- Dial Joins Forces with DonorsChoose and TeacherLists to Support Teachershttps://practicaldermatology.com/news/dial-joins-forces-with-donorschoose-and-teacherlists-to-supoort-teachers/2461264/Dial is doubling down on efforts to support teachers with a back-to-school marketing campaign. For the second year in a row, Dial has partnered with
- Sun Safety Day at Wrigley a Success for Sun Heroeshttps://practicaldermatology.com/news/sun-safety-day-at-wrigley-a-success-for-sun-heroes/2461261/As an extension of the Sun Heroes initiative, CeraVe's Sun Safety Day at Wrigley Field in partnership with Amy Brodsky, MD brought sun protection education to attendees as the Chicago Cubs hosted the Atlanta Braves. Dr. Brodsky founded
- Phase 3 PSOARING 3 Long-Term Extension Study Data Positive for Tapinarof Creamhttps://practicaldermatology.com/news/phase-3-psoaring-3-long-term-extension-study-data-positive-for-tapinarof-cream/2461251/New data from the one-year safety and efficacy final analyses of the Phase 3 PSOARING 3 long-term, open-label extension (“LTE”) study of Dermavant Sciences' VTAMA (tapinarof) cream, 1% for the treatment of plaque psoriasis in adults was published in the